We are live on ! Find out more
Man Group

Man Group Portfolio holdings

AUM $55.1B
1-Year Est. Return 24.23%
This Fund
S&P 500
This Quarter Est. Return
-3.8%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
AUM
$28.7B
AUM Growth
-$2.36B
Cap. Flow
-$1.76B
Cap. Flow %
-6.12%
Top 10 Hldgs %
13.82%
Holding
2,475
New
520
Increased
794
Reduced
717
Closed
314

Top Buys

Rank Stock Value
1
MU icon
Micron Technology
MU
+$155M
2
BIIB icon
Biogen
BIIB
+$132M
3
ZTS icon
Zoetis
ZTS
+$131M
4
AIG icon
American International
AIG
+$125M
5
KEYS icon
Keysight
KEYS
+$122M

Sector Composition

Rank Sector Weight
1 Technology 22.96%
2 Healthcare 13.83%
3 Financials 11.56%
4 Consumer Discretionary 11.06%
5 Industrials 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HDSN
1726
Hudson Technologies
HDSN
$267M
$255K ﹤0.01%
+41,021
New +$182K
SHOE
1727
Shoe Station Group
SHOE
$395M
$255K ﹤0.01%
8,726
+2,212
+34% +$72.1K
HLF icon
1728
Herbalife
HLF
$1.23B
$254K ﹤0.01%
8,353
-239,293
-97% -$9.36M
BWMN icon
1729
Bowman Consulting
BWMN
$454M
$253K ﹤0.01%
+15,375
New +$273K
CLPT icon
1730
ClearPoint Neuro
CLPT
$423M
$250K ﹤0.01%
+24,007
New +$219K
MSM icon
1731
MSC Industrial Direct
MSM
$7.02B
$250K ﹤0.01%
+2,938
New +$238K
SSBK
1732
DELISTED
Southern States Bancshares
SSBK
$250K ﹤0.01%
+10,857
New +$229K
ZEV
1733
DELISTED
Lightning eMotors, Inc.
ZEV
$247K ﹤0.01%
+2,164
New +$233K
CRNC icon
1734
Cerence
CRNC
$382M
$246K ﹤0.01%
6,795
+2,732
+67% +$135K
HRTX icon
1735
Heron Therapeutics
HRTX
$86.3M
$246K ﹤0.01%
+43,000
New +$315K
ROVR
1736
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$246K ﹤0.01%
+42,600
New +$255K
AWR icon
1737
American States Water
AWR
$3.39B
$245K ﹤0.01%
+2,741
New +$244K
CBT icon
1738
Cabot Corp
CBT
$4.65B
$245K ﹤0.01%
3,580
-124,967
-97% -$8.24M
GDYN icon
1739
Grid Dynamics Holdings
GDYN
$476M
$245K ﹤0.01%
+17,400
New +$356K
TVTX icon
1740
Travere Therapeutics
TVTX
$5.33B
$245K ﹤0.01%
+9,500
New +$252K
CRAI icon
1741
CRA International
CRAI
$1.1B
$244K ﹤0.01%
2,900
+500
+21% +$43.8K
IDA icon
1742
Idacorp
IDA
$8.23B
$244K ﹤0.01%
2,123
-2,403
-53% -$262K
DFTX
1743
Definium Therapeutics
DFTX
$5.73B
$244K ﹤0.01%
14,652
+7,359
+101% +$128K
VTLE
1744
DELISTED
Vital Energy
VTLE
$244K ﹤0.01%
+3,081
New +$223K
AXNX
1745
DELISTED
Axonics, Inc. Common Stock
AXNX
$242K ﹤0.01%
+3,860
New +$208K
ONEW icon
1746
OneWater Marine
ONEW
$214M
$240K ﹤0.01%
6,974
-5,900
-46% -$284K
ATC
1747
DELISTED
Atotech Limited
ATC
$240K ﹤0.01%
+10,947
New +$261K
ASB icon
1748
Associated Banc-Corp
ASB
$5.81B
$239K ﹤0.01%
+10,522
New +$255K
NPK icon
1749
National Presto Industries
NPK
$891M
$239K ﹤0.01%
+3,100
New +$252K
PING
1750
DELISTED
Ping Identity Holding Corp.
PING
$239K ﹤0.01%
8,726
-60,672
-87% -$1.27M

Similar funds

Man Group's Q1 2022 Portfolio in Review

As of Q1 2022, Man Group held 2,475 positions worth $28.7B, down 7.6% from $31.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Man Group withdrew a net $1.76B in Q1 2022, closing 314 positions and reducing 717 holdings. Its most notable exit was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $123M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Man Group opened a new position in Crown Castle worth $80.9M.

  • Man Group's largest Q1 2022 buy was Crown Castle: 438,151 shares worth $80.9M.
  • Man Group added most to Micron Technology in Q1 2022, an estimated $155M increase.
  • Man Group's biggest Q1 2022 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $181M.
  • Man Group fully exited State Street SPDR Bloomberg High Yield Bond ETF in Q1 2022, selling an estimated $123M.
  • Man Group's ten largest holdings make up 14% of its $28.7B portfolio in Q1 2022.
  • Man Group opened 520 new positions and closed 314 in Q1 2022.
  • Man Group's portfolio value fell 7.6% quarter-over-quarter to $28.7B.

Based on Man Group's 13F filing for Q1 2022, filed 16 May 2022.